China Isotope & Radiation Corp. (HK:1763) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
China Isotope & Radiation Corporation’s subsidiary, CNGT, has entered into an investment agreement with 404 Company and other investors to establish a joint venture named Gansu Hongye with a registered capital of RMB95 million. Under the agreement, 404 Company will hold a 60% stake, while CNGT will own 10% of the equity. This strategic move involves a connected transaction under Hong Kong’s listing rules, reflecting the company’s expansion efforts in collaboration with its parent entity, CNNC.
For further insights into HK:1763 stock, check out TipRanks’ Stock Analysis page.